In-vivo antidiabetic, lipid lowering and antioxidant activities of methanolic extaract of Lawsonia inermis leaves

Research Journal of Pharmacy and Technology

Volumn 4, Issue 5, 2011, Pages 764-767

  Chauhan, H V ^a  

^a Sudhakarrao Naik Institute of Pharmacy   (India)

Author keywords

Antidiabetic activity; Antihyperlipedemic; Antioxidant; Lawsonia inermis; Methhanolic extract

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIDIABETIC AGENT; ASPARTATE AMINOTRANSFERASE; GLIBENCLAMIDE; GLUCOKINASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LAWSONIA INERMIS EXTRACT; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; METHANOL; PLANT EXTRACT; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ACTIVITY; DRUG DOSE COMPARISON; FEMALE; GLUCOSE BLOOD LEVEL; IN VIVO STUDY; LAWSONIA INERMIS; LIPID LOWERING ACTIVITY; MALE; NONHUMAN; PLANT LEAF; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84855912902     PISSN: 0974360X     EISSN: 09743618     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Scheen, J.A., 1997. Drug treatment of non-insulin dependent diabetes mellitus in the 1990s. Achievement and future development. Drug, 54:355-368.
2. Lyra, R., M. Oliveira, D. Lins and N. Cavalcanti, 2006. Prevention of type 2 diabetes mellitus. Arq. Bras. Endocrinol. Metabo, 50: 239-249.
3. Morel, D.W. and G.M. Chisolm, 1989. Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity. J. Lipid Res., 30:1827-1834.
4. Granner, D.K., 1996. Hormones of the Pancreas and Gastrointestinal Tract. In: Murray, R.K., Granner, R.K., Mayes, P.A. and Rodwell, V.W. (Eds). Harper's Biochemistry, 24th Edn, Appleton and Lange, Connecticut, USA, pp: 586-587.
5. Oliver-Bever, B., 1986. Oral hypoglycemic action of medicinal plants in tropical West Africa. Cambridge University Press, London, pp: 245-267.
6. Rai, M.K., 1995. A review on some antidiabetic plants of India. Ancient Science of Life, 14: 42-54.
7. Loew, D. and M. Kaszkin, 2002. Approaching the problem of bioequivalence of herbal medicinal products. Phytother. Res., 16: 705-711.
8. Lavhate MS, Mishra SH. A review: nutritional and therapeutic potential of Ailanthus excelsa. Pharmacog Rev. 2007; 1(1):105-113.
9. Chetty KM. Flowering plants of Chittoor, Edn 1, Andhra Pradesh, 2008, pp. 132.
10. Chopra RN, Nayer SL, Chopra IC. Glossary of India Medicinal Plants, CSI Publications, New Delhi, 1956, pp. 151.
11. Arayne MS, Sultana N, Mirza AZ, Zuberi MH, Siddiqui FA. Invitro hypoglycemic activity of methanolic extract of some indigenous plants. Pak J Pharm Sci. 2007; 20(4):268-273.
12. Angel I, Burcelin R, Girard J, Salomon Z. Normalization of insulin secretion by selective alpha-2 adrenoceptor antagonist receptors GLUT-4 glucose transporter expression in adipose tissue of type-II diabetic rats. Endocrinology, 1996; 137: 2022-2027.
13. Badole S, Patel N. Antihyperglycemic activity of aqueous extract of leaves of Cocculus hirsutus in alloxan-induced diabetic mice. Indian Journal of Pharmacology, 2006; 38 (1):49-53.
14. Okokon JE, Bassey AL, Nwidu LL. Antidiabetic and Hypolipidaemic effects of ethanolic root extract of Setaria megaphylla; Int. J. of Pharmacol, 2007;3(1): 91-95.
15. Latner A, Majeed M, Badmeev V, Rajendran R. Piperine as bioavailability enhancer. US Patent 5, 744, 161, April 28, 1998.
16. John WB. Role of oxidative stress in the development of complications in diabetes. Diabetes 1991; 40: 405-12.
17. Matschinsky FM. Glucokinase, glucose homeostasis, and diabetes mellitus. Curr Diab Rep, 2000; 55 171-176
18. Matschinsky FM, Magnuson MA, Zelent D, Jetton TL, Doliba N, Han Y, Taub R, Grimsby J: The network of glucokinaseexpressing cells in glucose homeostasis and the potential of glucokinase activators for diabetes therapy. Diabetes, 2006; 55: 1-12.
19. Zelent D, Najafi H, Odili S et al. Glucokinase and glucose homeostasis: proven concepts and new ideas. Biochem Soc Trans, 2005; 33:306-310.
20. Richter J. Effect of adenosine analogues and cAMP-raising agents on TNF-, GM-CSF-, and chemotactic peptide-induced degranulation in single adherent neutrophils. J. Leukocyte Biol, 1992; 51: 270-275.
21. Cronstein BN, Rosenstein ED, Kramer SB, Weissmann G and Hirschhorn, R. Adenosine: A physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils. Initial pharmacological demonstration that the inhibitory effect of adenosine on neutrophils is mediated specifically by the A2AAR subtype. J. Immunol. 1985; 2:1366-1371.
22. Agius L. Glucokinase and molecular aspects of liver glycogen metabolism. Biochem J, 2008; 414:1-18.
23. Coghlan M, Leighton B. Glucokinase activators in diabetes management. Expert Opin Investig Drugs, 2008; 17:145-167.
24. Agius L. New hepatic targets for glycaemic control in diabetes. Best Pract Res Clin Endocrinol Metab, 2007; 21 587-605.
25. Basu A, Basu R, Shah P, Vella A, Johnson CM, Nair KS, Jensen MD, Schwenk WF, Rizza RA. Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity. Diabetes, 2000; 49:272-283.
26. Krssak M, Brehm A, Bernroider E, Anderwald C, Nowotny P, Dalla Man C, Cobelli C, Cline GW, Shulman GI, Waldhä usl W, Roden M: Alterations in Postprandial hepatic glycogen metabolism in type 2 diabetes. Diabetes, 2004; 53: 3048-3056.
27. Chi MS, Koh ET. Effect of garlic on lipid metabolism of rats fed with cholesterol or lard. J Nutr 1982; 112: 241-248.
28. Jaspreet V, Sivakami S, Shahini S, Antihyperglycemic effects of three extracts from Momordica charantia. J Ethnopharmacol 2003; 88: 107-111.